Your browser doesn't support javascript.
loading
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases.
Durfee, Cameron; Temiz, Nuri Alpay; Levin-Klein, Rena; Argyris, Prokopios P; Alsøe, Lene; Carracedo, Sergio; Alonso de la Vega, Alicia; Proehl, Joshua; Holzhauer, Anna M; Seeman, Zachary J; Liu, Xingyu; Lin, Yu-Hsiu T; Vogel, Rachel I; Sotillo, Rocio; Nilsen, Hilde; Harris, Reuben S.
Afiliación
  • Durfee C; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Temiz NA; Institute for Health Informatics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Levin-Klein R; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Argyris PP; Division of Oral and Maxillofacial Pathology, College of Dentistry, Ohio State University, Columbus, OH 43210, USA.
  • Alsøe L; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.
  • Carracedo S; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Alonso de la Vega A; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Translational Lung Research Center Heidelberg (TRLC), German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
  • Proehl J; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Holzhauer AM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Seeman ZJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Liu X; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Lin YT; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
  • Vogel RI; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN 55455, USA.
  • Sotillo R; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Translational Lung Research Center Heidelberg (TRLC), German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
  • Nilsen H; Department of Microbiology, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.
  • Harris RS; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA. Electronic address: rsh@uthscsa.edu.
Cell Rep Med ; 4(10): 101211, 2023 10 17.
Article en En | MEDLINE | ID: mdl-37797615
ABSTRACT
The antiviral DNA cytosine deaminase APOBEC3B has been implicated as a source of mutation in many cancers. However, despite years of work, a causal relationship has yet to be established in vivo. Here, we report a murine model that expresses tumor-like levels of human APOBEC3B. Animals expressing full-body APOBEC3B appear to develop normally. However, adult males manifest infertility, and older animals of both sexes show accelerated rates of carcinogenesis, visual and molecular tumor heterogeneity, and metastasis. Both primary and metastatic tumors exhibit increased frequencies of C-to-T mutations in TC dinucleotide motifs consistent with the established biochemical activity of APOBEC3B. Enrichment for APOBEC3B-attributable single base substitution mutations also associates with elevated levels of insertion-deletion mutations and structural variations. APOBEC3B catalytic activity is required for all of these phenotypes. Together, these studies provide a cause-and-effect demonstration that human APOBEC3B is capable of driving both tumor initiation and evolution in vivo.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Adult / Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos